| BioTelemetry is a remote medical technology company focused on delivery of health information. Co. provides remote cardiac monitoring, centralized core laboratory services, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. Co.'s segments are: Healthcare, which is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices; and Research, which is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, consulting and data management services for drug and medical device trials. We show 45 historical shares outstanding datapoints in our BEAT shares outstanding history coverage, used to compute BEAT market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BEAT market cap history over the course of time is important for investors
interested in comparing BEAT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BEAT versus a peer is one thing; comparing
BEAT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BEAT can fluctuate over the course of history.
With this page we aim to empower investors researching BEAT by allowing them to research the BEAT market cap history.